Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms

The cornerstone of pharmacotherapy for OCD is serotonin reuptake inhibition, either with clomipramine or with selective serotonin reuptake inhibitors (SSRIs). In spite of the success of serotonin reuptake inhibiting drugs, nearly half of OCD patients do not respond to treatment. Treatment response m...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Nieuwerburgh, Filip C.W., Denys, Damiaan A.J.P., Westenberg, Herman G.M., Deforce, Dieter L.D.
Formato: Texto
Lenguaje:English
Publicado: Informa Healthcare 2009
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824234/
https://www.ncbi.nlm.nih.gov/pubmed/20174590
http://dx.doi.org/10.3109/13651500902903016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824234/
https://www.ncbi.nlm.nih.gov/pubmed/20174590
http://dx.doi.org/10.3109/13651500902903016

Ejemplares similares